Trials / Completed
CompletedNCT01447537
Mechanisms Involved in the Benefits of an Exercise Programme in Patients With Cirrhosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The investigators conducted a pilot study including 17 patients with liver cirrhosis showing that a moderate exercise programme during three months increased thigh circumference,exercise tolerance and quality of life without adverse effects. The present study aim to more accurately evaluate the effect of exercise on muscle mass, effort tolerance and inflammatory response in patients with cirrhosis. This study will include 30 patients with compensated liver cirrhosis that will be randomized into two groups: exercise group and control group. Evaluation of muscle mass, effort tolerance, inflammatory response and quality of life will be made at the beginning and at the end of the study.
Detailed description
Exercise group: will do a physiotherapist supervised exercise programme 1 hour three times per week during three months and relaxation after exercise. Control group: only relaxation 1 hour three times per week during three months. Assessment: clinical and laboratory examinations performed at baseline and at the end of the study. The investigators will analyze the changes in muscle mass by anthropometric measurements and advanced techniques (CT scan, densitometry), effort tolerance (stress test), quality of life (sF-36), glutamine synthetase activity in blood, oxidative damage and inflammatory response. The investigators will analyze the survival and complications of cirrhosis during the study and follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exercise + relaxation | Exercise + relaxation |
| OTHER | Relaxation | Relaxation without exercise Patients will receive only relaxation for 3 months |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2011-10-06
- Last updated
- 2015-12-14
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01447537. Inclusion in this directory is not an endorsement.